FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kathleen Rickard

Research Profile

Chemicals & Drugs

Procedures

Disorders

Asthma

Phenomena

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Rohit Borker; Amanda Emmett; Priti Jhingran; Kathleen A Rickard; Paul Dorinsky
Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves.
Richard D O'Connor; Richard H Stanford; Courtney Crim; Steven W Yancey; Lisa Edwards; Kathleen A Rickard; Paul Dorinsky
Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
David I Bernstein; Arden Levy; Frank C Hampel; C A Baidoo; Cindy K Cook; Edward E Philpot; Kathleen A Rickard
Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kathleen Rickard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Rohit Borker; Amanda Emmett; Priti Jhingran; Kathleen A Rickard; Paul Dorinsky
Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2005;95(2):181-9.
2004: Richard D O'Connor; Richard H Stanford; Courtney Crim; Steven W Yancey; Lisa Edwards; Kathleen A Rickard; Paul Dorinsky
Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2004;93(6):581-8.
2004: David I Bernstein; Arden Levy; Frank C Hampel; C A Baidoo; Cindy K Cook; Edward E Philpot; Kathleen A Rickard
Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2004;34(6):952-7.
2004: Ketan Sheth; Cindy K Cook; Edward E Philpot; Barbara A Prillaman; Lori A Witham; Melissa A Faris; Kristofer C Klein; Kathleen A Rickard
Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
Allergy and asthma proceedings : the official journal of regional and state allergy societies 2004;25(2):115-20.
2004: Richard D O'Connor; Harold Nelson; Rohit Borker; Amanda Emmett; Priti Jhingran; Kathleen A Rickard; Paul Dorinsky
Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
PharmacoEconomics 2004;22(12):815-25.
2003: Jeffrey DeWester; Edward E Philpot; Ronald E Westlund; Cindy K Cook; Kathleen A Rickard
The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis.
Allergy and asthma proceedings : the official journal of regional and state allergy societies 2003;24(5):331-7.
2003: Mark S Dykewicz; Harold B Kaiser; Robert A Nathan; Stacey Goode-Sellers; Cindy K Cook; Lori A Witham; Edward E Philpot; Kathleen A Rickard
Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn).
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2003;91(1):44-8.
2003: Stanley P Galant; Isaac R Melamed; Anjuli S Nayak; Kathryn V Blake; Barbara A Prillaman; Kenneth D Reed; Cindy K Cook; Edward E Philpot; Kathleen A Rickard
Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients.
Pediatrics 2003;112(1 Pt 1):96-100.
2003: Paul H Ratner; William C Howland; Raiqua Arastu; Edward E Philpot; Kristofer C Klein; Charlotte A Baidoo; Melissa A Faris; Kathleen A Rickard
Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2003;90(5):536-42.
2002: David B Allen; Eli O Meltzer; Robert F Lemanske; Edward E Philpot; Melissa A Faris; Kenneth M Kral; Barbara A Prillaman; Kathleen A Rickard
No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year.
Allergy and asthma proceedings : the official journal of regional and state allergy societies 2002;23(6):407-13.
2002: William E Berger; Linda B Ford; Todd Mahr; Robert A Nathan; Courtney Crim; Lisa Edwards; Donna S Wightman; William R Lincourt; Kathleen A Rickard
Efficacy and safety of fluticasone propionate 250 microg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2002;89(4):393-9.
2002: John H Brabson; Dennis Clifford; Edward M Kerwin; Gordon Raphael; Pamela J Pepsin; Lisa D Edwards; Sharon Srebro; Kathleen A Rickard
Efficacy and safety of low-dose fluticasone propionate compared with zafirlukast in patients with persistent asthma.
The American journal of medicine 2002;113(1):15-21.
2002: Eli O Meltzer; Richard F Lockey; Bruce F Friedman; Christopher Kalberg; Stacey Goode-Sellers; Sharon Srebro; Lisa Edwards; Kathleen A Rickard
Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
Mayo Clinic proceedings. Mayo Clinic 2002;77(5):437-45.
2002: D Robert Webb; Eli O Meltzer; Albert F Finn; Kathleen A Rickard; Pamela J Pepsin; Ronald E Westlund; Cindy K Cook
Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2002;88(4):385-90.
2002: Peter S Creticos; Katharine Knobil; Lisa D Edwards; Kathleen A Rickard; Paul Dorinsky
Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2002;88(4):401-9.
2002: David S Pearlman; Martha V White; Allen K Lieberman; Pamela J Pepsin; Christopher Kalberg; Amanda Emmett; Brian Bowers; Kathleen A Rickard; Paul Dorinsky
Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2002;88(2):227-35.
2002: Ketan Sheth; Rohit Borker; Amanda Emmett; Kathleen A Rickard; Paul Dorinsky
Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
PharmacoEconomics 2002;20(13):909-18.
2001: William J Calhoun; Harold S Nelson; Robert A Nathan; Pamela J Pepsin; Christopher Kalberg; Amanda Emmett; Kathleen A Rickard; Paul Dorinsky
Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone.
American journal of respiratory and critical care medicine 2001;164(5):759-63.
2001: J E Fish; E Israel; John Joseph Murray; Amanda Emmett; R Boone; Steven W Yancey; Kathleen A Rickard
Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Chest 2001;120(2):423-30.
2001: Harold S Nelson; Robert A Nathan; Christopher Kalberg; Steven W Yancey; Kathleen A Rickard
Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
MedGenMed : Medscape general medicine 2001;3(4):3.
2001: William W Busse; J Wolfe; W Storms; Sharon Srebro; Lisa Edwards; M Johnson; B W Bowers; PR Rogenes; Kathleen A Rickard
Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
The Journal of family practice 2001;50(7):595-602.
2001: S W Stoloff; Sharon Srebro; Lisa D Edwards; M C Johnson; Kathleen A Rickard
Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate.
MedGenMed : Medscape general medicine 2001;3(3):2.
2001: Richard ZuWallack; Donald A Mahler; D Reilly; NL Church; Amanda Emmett; Kathleen A Rickard; Katharine Knobil
Salmeterol plus theophylline combination therapy in the treatment of COPD.
Chest 2001;119(6):1661-70.
2001: Paul Dorinsky; Lisa D Edwards; Steven W Yancey; Kathleen A Rickard
Use of changes in symptoms to predict changes in lung function in assessing the response to asthma therapy.
Clinical therapeutics 2001;23(5):701-14.
2001: J Matz; Amanda Emmett; Kathleen A Rickard; Christopher Kalberg
Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations.
The Journal of allergy and clinical immunology 2001;107(5):783-9.
2001: Eli O Meltzer; Kathleen A Rickard; Ronald E Westlund; Cindy K Cook
Onset of therapeutic effect of fluticasone propionate aqueous nasal spray.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2001;86(3):286-91.
2001: William W Busse; Gordon Raphael; S Galant; Christopher Kalberg; Stacey Goode-Sellers; Sharon Srebro; Lisa Edwards; Kathleen A Rickard
Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
The Journal of allergy and clinical immunology 2001;107(3):461-8.
2001: R Menendez; R H Stanford; Lisa Edwards; Christopher Kalberg; Kathleen A Rickard
Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma.
PharmacoEconomics 2001;19(8):865-74.
2000: Harold S Nelson; William W Busse; Edward M Kerwin; NL Church; Amanda Emmett; Kathleen A Rickard; Katharine Knobil
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
The Journal of allergy and clinical immunology 2000;106(6):1088-95.
2000: K T Kim; E J Ginchansky; B F Friedman; Sharon Srebro; Pamela J Pepsin; Lisa Edwards; R H Stanford; Kathleen A Rickard
Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2000;85(5):398-406.
2000: Eugene R Bleecker; M J Welch; S F Weinstein; Christopher Kalberg; M Johnson; Lisa Edwards; Kathleen A Rickard
Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma.
The Journal of allergy and clinical immunology 2000;105(6 Pt 1):1123-9.
1999: Steven G Kelsen; NL Church; S A Gillman; B Q Lanier; Amanda Emmett; Kathleen A Rickard; Wayne H Anderson
Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial.
The Journal of asthma : official journal of the Association for the Care of Asthma 1999;36(8):703-15.
1999: James N Baraniuk; John Joseph Murray; Robert A Nathan; William E Berger; M Johnson; Lisa D Edwards; Sharon Srebro; Kathleen A Rickard
Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Chest 1999;116(3):625-32.
1999: Richard R. Rosenthal; William W Busse; J P Kemp; J W Baker; Christopher Kalberg; Amanda Emmett; Kathleen A Rickard
Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Chest 1999;116(3):595-602.
1999: Robert A Nathan; J L Pinnas; HJ Schwartz; J Grossman; Steven W Yancey; Amanda Emmett; Kathleen A Rickard
A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1999;82(6):521-9.
1999: L Wiegand; C N Mende; G Zaidel; C W Zwillich; V J Petrocella; Steven W Yancey; Kathleen A Rickard
Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Chest 1999;115(6):1525-32.
1999: William W Busse; H Nelson; J Wolfe; Christopher Kalberg; Steven W Yancey; Kathleen A Rickard
Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
The Journal of allergy and clinical immunology 1999;103(6):1075-80.
1999: John Joseph Murray; NL Church; Wayne H Anderson; D I Bernstein; S E Wenzel; Amanda Emmett; Kathleen A Rickard
Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases.
Allergy and asthma proceedings : the official journal of regional and state allergy societies 1999;20(3):173-80.
1999: Gordon Raphael; R Q Lanier; J Baker; Lisa Edwards; Kathleen A Rickard; William R Lincourt
A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma.
The Journal of allergy and clinical immunology 1999;103(5 Pt 1):796-803.
1999: Harold S Nelson; R B Berkowitz; D A Tinkelman; Amanda Emmett; Kathleen A Rickard; Steven W Yancey
Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
American journal of respiratory and critical care medicine 1999;159(5 Pt 1):1556-61.
1999: J J Condemi; S Goldstein; Christopher Kalberg; Steven W Yancey; Amanda Emmett; Kathleen A Rickard
The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1999;82(4):383-9.
1999: Donald A Mahler; James F Donohue; R A Barbee; M D Goldman; N J Gross; M E Wisniewski; Steven W Yancey; B A Zakes; Kathleen A Rickard; Wayne H Anderson
Efficacy of salmeterol xinafoate in the treatment of COPD.
Chest 1999;115(4):957-65.
1999: Richard F Lockey; L M DuBuske; B Friedman; V Petrocella; FM Cox; Kathleen A Rickard
Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes.
Chest 1999;115(3):666-73.
1998: W W Busse; T B Casale; John Joseph Murray; V Petrocella; FM Cox; Kathleen A Rickard
Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
The American journal of managed care 1998;4(11):1579-87.
1998: A D Adinoff; HJ Schwartz; Kathleen A Rickard; Steven W Yancey; B E Swearingen
Salmeterol compared with current therapies in chronic asthma.
The Journal of family practice 1998;47(4):278-84.
1998: S E Wenzel; W Lumry; M Manning; Christopher Kalberg; FM Cox; Amanda Emmett; Kathleen A Rickard
Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1998;80(6):463-70.
1998: J P Kemp; D A Cook; G A Incaudo; J Corren; Christopher Kalberg; Amanda Emmett; FM Cox; Kathleen A Rickard
Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.
The Journal of allergy and clinical immunology 1998;101(2 Pt 1):188-95.
1996: Kathleen A Rickard; FM Cox; LJ Okamoto; R Mills
A cost comparison of beta 2-agonist bronchodilators is not a cost-effectiveness comparison.
Pharmacotherapy 1996;16(3):484-5; discussion 486-7.